Coronary Artery Disease News and Research

Latest Coronary Artery Disease News and Research

Reducing heart failure deaths: an interview with Dimitrios Georgiopoulos, UK Medical Director, Novartis

Heart failure is a debilitating, and life-threatening, condition in which the heart cannot pump enough blood around the body. When heart failure continues to progress and worsen over time, the persistent condition is known as chronic heart failure.

From Novartis 16 Oct 2014

New study reviews modern treatment modalities for early-stage lung cancer

Removal of the entire lobe of lung may offer patients with early-stage lung cancer better overall survival when compared with a partial resection, and stereotactic ablative radiotherapy (SABR) may offer the same survival benefit as a lobectomy for some patients, according to a study from The University of Texas MD Anderson Cancer Center.

16 Oct 2014

Boehringer Ingelheim's OFEV (nintedanib) capsules receive FDA approval for IPF treatment

Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration approved OFEV (nintedanib) capsules for oral use for the treatment of idiopathic pulmonary fibrosis (IPF).

15 Oct 2014

Obesity, other cardiovascular issues to be the focus of Brazilian Congress of Cardiology

More than 4,000 extra wide seats were made to accommodate Brazil's increasing obese population during the World Cup this year. Obesity affects nearly 20 percent of the population in Brazil and is currently classified as a disability. This and other cardiovascular issues, such as the overuse of technology, will be the focus of the Brazilian Congress of Cardiology, a joint event with the European Society of Cardiology and the Brazilian Society of Cardiology, 26-29 September.

23 Sep 2014

South Asians in Canada have higher rate of heart disease compared with white people

South Asians living in Canada have a higher rate of heart disease and double the rate of diabetes compared with while people, McMaster researchers have found.

23 Sep 2014

Lobectomy and segmentectomy have similar efficacy in stage I NSCLC

Lobectomy and anatomic segmentectomy appear to offer similar perioperative and oncological outcomes in patients with stage I non-small-cell lung cancer, analysis suggests.

17 Sep 2014

Abbott announces initiation of ABSORB IV heart stent clinical trial

Abbott announced today the start of the ABSORB IV clinical trial, which will test whether its Absorb Bioresorbable Vascular Scaffold (BVS) is more cost-effective and offers a higher quality of life than a best-in-class, permanent, metallic drug eluting stent.

16 Sep 2014

Researchers develop new methods that improve quality of myocardial perfusion imaging

New methods that enhance the quality of myocardial perfusion imaging were developed in a recent study completed at the University of Eastern Finland.

9 Sep 2014

Researchers uncover intriguing link between heart attacks and protein

A team of researchers at the University of Ottawa Heart Institute, led by Dr. Alexandre Stewart, have uncovered an intriguing link between heart attacks and a protein that is of great interest to drug companies for its impact on cholesterol.

4 Sep 2014

Measuring levels of sex hormones in patients' blood may identify risk of sudden cardiac arrest

Measuring the levels of sex hormones in patients' blood may identify patients likely to suffer a sudden cardiac arrest, a heart rhythm disorder that is fatal in 95 percent of patients.

3 Sep 2014

FFR guided drug-eluting stenting reduces death compared to medical therapy in stable CAD patients

Fractional flow reserve (FFR)-guided drug-eluting stenting reduces death, myocardial infarction or urgent revascularisation, as compared to medical therapy in patients with stable coronary artery disease (CAD), according to the results of the FAME 2 trial presented for the first time today at ESC Congress by principal investigator Dr Bernard De Bruyne (Belgium).

2 Sep 2014

Measuring coronary artery blockage in heart attack patients can help avoid surgery

A method for measuring coronary artery blockage in heart attack patients can help more than one fifth of them avoid stents or surgery, according to a British study presented at the ESC Congress 2014 today.

1 Sep 2014

Janssen, Bayer announce expansion of EXPLORER global cardiovascular research program for XARELTO

Janssen Research & Development, LLC and its development partner, Bayer HealthCare, announced today the expansion of the EXPLORER global cardiovascular research program for XARELTO (rivaroxaban) to include additional high-risk patient populations.

29 Aug 2014

Philips to highlight full range of cardiology solutions at ESC Congress 2014

Royal Philips today announced its presence at the European Society of Cardiology Congress 2014, where the company is highlighting the full range of its cardiology solutions serving clinicians and patients across the care continuum from prevention and diagnosis, to treatment, recovery and wellness.

From Philips Healthcare 29 Aug 2014

Sanofi, Regeneron present alirocumab Phase 3 trial results at ESC Congress 2014

Regeneron Pharmaceuticals, Inc. and Sanofi today announced that details from four pivotal trials in the alirocumab ODYSSEY clinical program will be presented on Sunday, August 31, during a Hot Line session at ESC Congress 2014 in Barcelona, Spain, the world's largest cardiology meeting.

25 Aug 2014

Coronary Artery Disease News and Research

Latest Coronary Artery Disease News and Research

Reducing heart failure deaths: an interview with Dimitrios Georgiopoulos, UK Medical Director, Novartis

New study reviews modern treatment modalities for early-stage lung cancer

Boehringer Ingelheim's OFEV (nintedanib) capsules receive FDA approval for IPF treatment

Obesity, other cardiovascular issues to be the focus of Brazilian Congress of Cardiology

South Asians in Canada have higher rate of heart disease compared with white people

Lobectomy and segmentectomy have similar efficacy in stage I NSCLC

Abbott announces initiation of ABSORB IV heart stent clinical trial

Researchers develop new methods that improve quality of myocardial perfusion imaging

Researchers uncover intriguing link between heart attacks and protein

Measuring levels of sex hormones in patients' blood may identify risk of sudden cardiac arrest

FFR guided drug-eluting stenting reduces death compared to medical therapy in stable CAD patients

Measuring coronary artery blockage in heart attack patients can help avoid surgery

Janssen, Bayer announce expansion of EXPLORER global cardiovascular research program for XARELTO

Philips to highlight full range of cardiology solutions at ESC Congress 2014

Sanofi, Regeneron present alirocumab Phase 3 trial results at ESC Congress 2014

Endothelial cells can function as cardiac stem cells to produce new heart muscle tissue

Royal Philips receives 510(k) clearance from FDA for TAVI treatments

Researchers find current blood pressure recommendations for older patients

ASAHI INTECC, Boston Scientific to develop new, differentiated FFR wire

Patients treated with drug for type 2 diabetes can live longer than people without the condition

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Coronary Artery Disease News and Research

Latest Coronary Artery Disease News and Research

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Newsletters you may be interested in